In this study we report that the Pcyt2 + /- liver methylome and transcriptome is altered and likely underlies much of the pathological development of NASH in Pcyt2 + /- mice. This evidence concerns the gene PCYT2 and metabolic dysfunction-associated steatohepatitis.